Neurology Equipment segmentation by type delineates four primary categories that collectively define the market's revenue composition. Diagnostic devices, encompassing electroencephalography (EEG), magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET) systems, represent the largest share, driven by the growing demand for high‑resolution neuroimaging in disease identification. Therapeutic equipment, such as deep brain stimulation (DBS) generators, transcranial magnetic stimulation (TMS) units and peripheral neurostimulation devices, contributes a secondary but rapidly expanding portion, reflecting increased adoption of minimally invasive interventions. Monitoring solutions—including intracranial pressure (ICP) monitors, electromyography (EMG) and continuous vital‑sign platforms—account for a modest segment, primarily supporting intensive care and postoperative surveillance. Surgical instruments, notably neuronavigation platforms, operative microscopes and stereotactic frames, form the smallest yet strategically important slice, as they enable precision procedures that command premium pricing. Regulatory pathways, reimbursement structures, and the diffusion of digital integration further differentiate the revenue trajectories of each type, with diagnostic devices benefiting from broader insurance coverage, while therapeutic and surgical categories experience higher unit prices but slower volume growth. This type‑based taxonomy underpins the overall Neurology Equipment market size.
